CURRICULUM VITAE PROFESSOR LYNNE MARGARET WEBBER MBChB (Pret), M Med Path (Virol) cum laude, DTH (Diploma in Tropical Health) cum laude Head of Department: Department of Medical Virology School of Medicine Faculty of Health Sciences University of Pretoria Clinical Virologist and Consultant Pathologist: National Health Laboratory Service (NHLS) Tshwane Academic Division (TAD) ADDRESS ALL CORRESPONDENCE TO: Professor LM Webber Private Bag X323 Arcadia Pretoria South Africa 0007 Tel: (012) 319 2656 Fax: (012) 325 5550 Email: [email protected]/ [email protected] Cell: 082 555 7724 NAME: LYNNE MARGARET WEBBER MARITAL STATUS: MARRIED DATE OF BIRTH: 31 DECEMBER 1965 NATIONALITY: SOUTH AFRICAN (born in Port Elizabeth, Eastern Cape Province) HEALTH: EXCELLENT No criminal record HOBBIES AND INTERESTS: Guinea pig breeding, dressage and show jumping, sports horse breeding, fly-fishing, cuisine cooking, amateur astronomy SPORT ACHIEVEMENTS: JUDO - Eastern Province Judo team 1983 Western Province Judo team 1984 SHOWJUMPING: Northern Transvaal Show jumping team 1996, 1997 Currently individual showjumper for The Horse Society, Gauteng. CURRENT SPORTING ACTIVITIES: Showjumping: member of The Horse Society Member of the South African Warmblood Society SCHOOLING: St Dominic‟s Priory Catholic School for Girls - Port Elizabeth Collegiate High School for Girls - Port Elizabeth Awards: Academic School Colours Numerous prizes for academic excellence in Latin, English, Science and Biology Matriculation: First class pass 2 ACADEMIC QUALIFICATIONS: MBCHB - University of Pretoria, 1990 Distinction in Paediatrics Prizes: Virology prize Microbiology prize Ear, nose and throat surgical prize Paediatric prize Bursary: University Merit Award - first year to sixth year. M Med Path (Virol) cum laude - University of Pretoria, 1998 1994 - 1996: junior registrar post with rotations in haematology, chemical pathology, anatomical pathology, medical microbiology, medical virology, immunology 1996 - 1998: senior registrar post in medical virology Dissertation: Assessment of commercial enzyme immunoassay for hepatitis C virus serotyping (published in Journal of Clinical Pathology 1996;49:994-997). Diploma in Tropical Health (DTH) cum laude - University of Pretoria and the Transvaal School of Public Health, 1998 ACADEMIC AWARDS: University of Pretoria Dux Docens Award, for outstanding service to the student community, 1998; Faculty of Medicine Merit Award, for outstanding results received in the M Med Path (Virol) examinations, 1998; Lecturer of the Year - MBCHB II class award for 1999. RESEARCH AWARDS AND RECOGNITION: Best Publication for a Team Effort: Faculty of Medicine 1999, first author; Best Publication for a Young Researcher: Faculty of Medicine 2000, co-author; Top Ten Most Productive Researchers: of all categories of research output at the University of Pretoria, 2000; Outstanding Young Researcher: University of Pretoria, 2001; Best Oral Presentation: National Testing and Measurement Congress, Pretoria, September 3 2001; Award for recognition of Original Research Paper: Infectious Diseases Congress, Cape Town, December 2001; Best Overall Presentation and Paper: National Test and Measurement Conference, Emperor‟s palace, Gauteng, September 2005; Best Overall Publication – Qualitative Research, runner-up, Faculty of Health Sciences, University of Pretoria, 2010. RESEARCH GRANTS AND FINANCIAL ASSISTANCE: MRC grant for research on bloodborne viruses and occupational exposures - 1998 – 2000; Research Development Programme of the University of Pretoria grant for research on HIV and occupational exposure risks - 1998 – 2000; MRC Unit for Maternal and Infant Health Care Strategies support for the Pretoria Pasteurisation Study and HIV culture research – 2000; USAIDS grant for work and research on home based care kits with the Study for the Centre of AIDS in Africa, University of Pretoria - 2000 – 2001; University of Pretoria Grant - HIV research and management modalities, 2000 – 2001; International grant from Wild Life Organisation on HIV, HBV and HCV infectivity in semen samples. Re -awarded for 2005; Phidisa project (collaborative HIV and HBV international testing and management research protocol) – funded by the United States National Institute of Health (NIH) – 2003 – 2008; International Wildlife Foundation – Pathogen (bacterial and viral) removal from semen specimens, re-awarded for 2005; African and European Viral Hepatitis Joint Initiative – hepatitis B virus (HBV) research, 2000-2003; University of Pretoria Study – bloodborne pathogens in occupational settings, in particular bone dust specimens from mortuary HIV-infected individuals, completed 2004; Consultant Pathologist and Advisor, Bio-Analytical Research Centre (Belgium and 4 South Africa), for numerous clinical trials, 2007; Bloodborne viral pathogens – in collaboration with the Department of Forensic Medicine, 2009-2015; Clinical trial – an open phase 2 study in Human Immunodeficiency virus 1 infected untreated male adult patients to evaluate safety and tolerability and the in vivo effects on T-cell populations and viral load of a Gonadotropin releasing hormone-analogue administrated by intranasal administration during 28 days when combined with a single intramuscular testosterone depot injection to restore a normal blood testosterone level. University of Pretoria Clinical Trials Unit (protocol number 78/2010, ethical approval from the Faculty of Health Sciences Research Ethics Committee 13/04/2011), principal investigator, 2010-2014; PROFESSIONAL REGISTRATIONS: 1990: Healthcare Professions Council South Africa (HPCSA) as a general practitioner (MBChB Pret) 1998: HPCSA as a pathologist specialist (Clinical Virologist, Med Path Virol) 1999: HPCSA, registration of Diploma in Tropical Health (DTH Pret) PROFESSIONAL SOCIETY MEMBERSHIP: Current – 2014: Infectious Diseases Society of Southern Africa - affiliated to the Federation of South African Societies of Pathology (FSSAP); South African HIV Clinicians Society; National Antimicrobial Surveillance Forum; South African Medical Association (SAMA) Continuing Professional Development (CPD) Committee. PROFESSIONAL EXPERIENCE: 1991: House doctor at Provincial Hospital, Port Elizabeth, rotations in Internal Medicine, Paediatrics, Anaesthetics, General Surgery, Urology and Obstetrics and Gynaecology; 1992: Medical officer, Radiotherapy Department, Provincial Hospital, Port Elizabeth; 1993: Medical officer, Medical Oncology Department, Pretoria Academic Hospital, Pretoria; 1994: Junior registrar in Pathology, Institute of Pathology, University of Pretoria; 5 1996: Senior registrar, Department of Clinical Virology, University of Pretoria; 1998: Specialist/lecturer, Department of Medical Virology, University of Pretoria; 1999: Senior specialist, Department of Medical Virology, University of Pretoria; 2003: Acting Head, Department of Medical Virology, Faculty of Health Sciences, University of Pretoria; 2004: Consultant Pathologist and Clinical Virologist, Lancet Laboratories, BARC SA Clinical Trials Unit; 2009: Head of the Department of Medical Virology, Institute of Pathology, Faculty of Health Sciences, University of Pretoria – current post. PRESENT POSITION: Full time duties: dual appointment Head of Department, Department of Medical Virology, Faculty of Health Sciences, University of Pretoria; Consultant Pathologist and Clinical Virologist, NHLS TAD. Contractual duties: HIV Advisor, HIV Your Life programme, Polmed Business Unit, Metropolitan Health Management, South Africa Additional duties: Clinical Trials Advisor, Clinical Trials Unit, University of Pretoria – current; Editorial Board, Journal of Human Virology and Retrovirology - current; Invited reviewer, Southern African Journal of Infectious Diseases - current; Organising Committee of the 54th FSASP International Unipath Conference, CSIR ICC, Pretoria - completed; Member of the Recruitment and Selection Committee, Faculty of Health Sciences, University of Pretoria - current. 6 EXPERIENCE AND ACHIEVEMENTS: Consultant for Niehaus and Botha Laboratory, Pretoria - occupational advice and services, particularly with respect to staff exposure to bloodborne viruses, expired; Involvement in many consultations on HIV related and bloodborne matters, nationally and internationally, for countries such as Zimbabwe, Alaska, Kenya, Uganda; Technical assessor for SANAS (South African National Accreditation System), registered May 2007, TA 070; Lead assessor for SANAS, registered May 2007, LA025; Technical expert for LOALAC accreditation purposes; Many presentations at various meetings and seminars, such as those arranged by SAMA (South African Medical Association), South African Society of Occupational Medicine (SASOM) and pharmaceutical companies such as GlaxoWellcome and Aspen-Phramacare: Medical faculty representative for the Centre for the Study of AIDS in Africa, University of Pretoria and actively engaged in many community, University, research projects and initiatives; Involved with the planning of the GlaxoWellcome Starter-pack anti-retroviral prophylaxis for healthcare students nationwide, expired; Actively involved with the Student Committee of the University of Pretoria on occupational health and safety matters, including insurance for possible HIV contraction occupationally and the management and prevention of needle stick and related injuries in the work place; Member of the organising committee: Futurepath - 98, Annual Congress of the Federation of the South African Societies of Pathology, July 1998, completed; 7 Active community involvement includes numerous radio interviews and magazine and newspaper quotes and articles. Recent interviews for E-TV, 2005 - 2014, HIV-related matters and avian influenza; Expert Witness on HIV Medicine, Supreme Court of South Africa, Johannesburg, 2003; Expert Witness on antiretroviral agents, Pietermaritzburg high Court, 2002 – 2003; ConsultantVirologist, Vermaak and Partners Pathology Group, terminated, December 2003; Consultant Virologist, Toga Laboratories, South Africa, terminated December 2003: Examiner, moderator and convenor for the College of Medicine, (CMSA, FC Path Viro SA), Clinical Virology; Member of the HIV Vaccine Committee, Medicines Control Council, on, as External Advisor, completed; Member of the HIV Committee, Compensation Commissioners Office, National Department of Health, completed 2003; Medical Advisor and Clinical Virologist, HIV Protocol, Civil Aviation Authority for South Africa, completed; Member of the Tamiflu Advisory Board, 2007; completed; Expert witness, Supreme Court, Pietermaritzburg, South Africa, 2012-2014; Member of the Recruitment Selection Committee, Faculty of Health Sciences, University of Pretoria, current. 8 MEMBERSHIP OF FACULTY, HOSPITAL-RELATED AND OTHER COMMITTEES: Infectious Diseases Forum, University of Pretoria; Pathology Group Committee – Steve Biko Academic Hospital, Office of the Medical Superintendent; Health Research Ethic‟s Committee of the University of Pretoria - adverse events, completed; Organising Committee – Scientific Programme. Medical Virology Congress of South Africa, 18-21 May 2003, Kruger National Park, South Africa, completed; Member: Organising Committee, Unipath 54th FSASP International Congress 2014, CSIR ICC, 15-19 September 2014, Pretoria, South Africa. RESEARCH: Current research projects and completed programmes include: HIV diagnosis using molecular techniques; Lancet Laboratories and BARC Clinical trial Unit (completed); Occupational risks and hazards for students, professionals and auxiliary workers in the health-care environment; HIV prophylaxis for sexual assault; Opportunistic infections in HIV-positive patients; BARC Clinical trials Unit (completed); Risk and prognosis assessment of HIV-positive individuals admitted to ICU (completed); Enteroviral and herpes virus infections of the central nervous system (completed); HIV transmission in breastmilk and the prevention thereof (completed); HIV and social science aspects; through the Centre for the Study of AIDS, University of Pretoria, Annamarie Bindenagel Foundation and Consultants, private initiative with a private practitioner in Lenasia (completed); HIV and home based care kits for the community (completed); HIV and other pathogen (bacterial and viral) survival in specially treated semen specimens, o through the University of Pretoria, the World Wildlife Fund and the Omahau Zoo, United States of America, (completed); HIV infectivity in mortuary bone dust; Bloodborne viruses in Forensic Medical Practice; Bloodborne viruses and co-infections; 9 Bloodborne viruses in clinical medicine; Laboratory testing for bloodborne viruses in clinical specimens. GRANT APPLICATIONS, 2006 – 2014: Discovery Health Foundation Award – R90 000 – HIV-1 genetic diversity project Immune System Regulation, Karolinska University Hospital Solna, Stockholm, Sweden (Project Manager) – principal investigator, clinical trial, – rational for the evaluation of gonadotropin releasing hormone administration in HIV disease; Annual NHLS Research grant; Discovery Health Research Grant, renewal. (2013-2014). CLINICAL ACTIVITIES AND EXPERIENCE: Registered in Clinical Virology at Health Professions Council of South Africa (HPCSA); Medical Advisor for Polmed HIV Your Life programme, Metropolitan Health Management, South Africa; Consultant for HIV Medical matters for the SA HIV Clinicians Society; Infection Control and General Pathology meetings, Steve Biko Academic Hospital; Clinical case presentations at Steve Biko Academic Hospital, Kalafong Academic Hospital, Gauteng; Clinical outreach programmes to Polokwane (Limpopo Province) and Nelspruit (Mmpumalanga Province) districts; Clinical case presentations tutorials at the Department of Medical Virology, Faculty of Health Sciences, University of Pretoria, weekly Journal presentations weekly, Department of Medical Virology, Faculty of Health Sciences,University of Pretoria; Clinical ward rounds, Polmed HIV Your Life programme Offices (Metroploitsn Health Management), in Pretoria, weekly; Consultant Pathologist and Clinical Virologist, Department of Medical Virology, Faculty of Health Sciences, University of Pretoria/NHLS TAD. 10 PUBLICATIONS IN PEER-REVIEWED JOURNALS INTERNATIONAL JOURNALS 1. Webber LM. Els S, Taylor MB, Grabow WOK Assessment of commercial enzyme immunoassay for hepatitis C virus serotyping. Journal of Clinical Pathology 1996;49:994-997 2. Du Plessis R, Webber LM. Saayman G. Bloodborne viruses in forensic medical practice in South Africa. American Journal of Forensic and Medical Pathology 1999:20(4):364-366. (This article was awarded Best Publication by a Junior Researcher, Faculty of Medicine, University of Pretoria, 2000) 3. Webber LM. Saliva for diagnostics. World Health Organisation Bulletin, Second Quarter, July 1997 4. Hepatitis B virus - a major threat in African children with cancer. Willers E, Delport, Webber LM, Kruger M. Journal of Tropical Paediatrics, September 2001;47:220225. (This article was awarded Article of the Month by the International Journal fraternity, September 2001) 5. Jeffery BS, Webber L, Mokhondo R, Erasmus D. Determination of the effectiveness of inactivation of human immunodeficiency virus by Pretoria pasteurization. Journal of Tropical Paediatrics 2001;47:345-349 (This article was awarded Article of the Month by the International Journal fraternity, December 2001) (This article received a Merit Award for the Best Overall Publication, Faculty of Health Sciences, University of Pretoria, 2002) 6. Loskutoff NM, Huyser C, Singh R, Morfield KA, Walker DL, Thornhill AR, Smith M, Morris L, Webber L. A novel and effective procedure for removing HIV-1 and hepatitis B and C viruses from spiked human semen. Reproduction, Fertility and Development 2004;17(2):243-243. 7. Loskutoff NM, Huyser C, Singh R, Morfield KA, Walker DL, Thornhill AR, Smith M, Morris L, Webber L. A novel and effective procedure for removing HIV-1 RNA from human semen. Research Papers in Fertility and Reproductive Medicine (International Congress Series) 2004;1271C:200-204. 8. Loskutoff NM, Huyser C, Singh R, Morfield KA, Walker DL, Thornhill AR, Smith M, Morris L. Webber L. Removing HIV-1 and hepatitis C virus from semen: an improved method using a trypsinized silica particle suspension and a novel tube insert device. Research Papers in Fertility and Sterility (International Congress Series), 2004;1271C:200-206. 11 9. Loskutoff NM, Huyser C, Singh R, Walker DL, Thornhill AR, Morris L, Webber L. Use of a novel washing method combining multiple density gradients and trypsin for removing human immunodeficiency virus and hepatitis C virus from semen. Fertility and Sterility 2005;84(4):1001-1010. 10. Weber B, Orazi B, Raineri A, Thorstensson R, Burgisser P, Muhlbacher A, Areal C, Eiras A, Villaescusa R, Camacho R, Diogo I, Roth HJ, Zahn I, Bartel J, Bossi V, Piro F, Atamasirikul K, Permpikul P, Webber L, Singh S. Multicenter evaluation of a new 4th generation HIV screening assay Elecsys HIV combi. Clinical Laboratories 2006;52(9- 10):463-473. 11. Syebele K, Butow K-W, Webber LM, Manda S. Quantification of HIV-1 viral load in the fluid of ranulas in HIV-positive patients. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Edontology (OOOOE) 2011;111:715-719. 12. Morobadi MD, Webber LM. Growing up with HIV in Southern Africa – HIV-infected children and adolescents. Journal of Human Virology and Retrovirology (JHVRV) 2014;1(1)0005 12 NATIONAL JOURNALS 1. Grabow WOK, Taylor BM, Webber LM. Hepatitis E virus in South Africa. South African Journal of Science 1996;92:178-180. 2. Webber LM, Grabow WOK, Favorov M, Fields H. Comparison of two enzyme immunoassays for the detection of antibodies to hepatitis E virus. Southern African Journal of Epidemiology and Infection 1998;13:16-19. (This article received Best Publication for a Team Effort, Faculty of Medicine, University of Pretoria, 1999) 3. Webber LM, Swanevelder C, Grabow WOK, Fourie B. Evaluation of a rapid test for HIV antibodies in saliva and blood. South African Medical Journal 2000;90:10041007. 4. Webber LM. Needlestick injuries and healthcare students – review article. Occupational Health SA 1999:5(6);31-33. 5. Mphahlele MJ, Jenscj S, Clay CG, Moloto MJ, Smit EJ, van der Merwe CF, Webber LM. HBV viral load testing: clinical significance and choice of assay. Letter, South African Medical Journal 2001, March 99. 6. Webber LM. Richards P, Grey S. HIV prophylaxis: are South African health-care students being neglected. South African Journal of Science 2000;96:295-296 7. Webber LM. Bloodborne viruses and occupational exposure in the dental setting review article. South African Dental Journal 2000;55:381-382. 8. Webber LM. Viral hepatitis. Health and Hygiene 2000;11:10-12. 9. Webber LM. Prevention and prophylaxis for certain viral infections. Southern African Journal of Epidemiology and Infection 2000;15:80-83 10. Erasmus B, Gous P, Webber LM. Rapid adenovirus diagnosis in ocular specimens from clinically selected patients. Southern African Journal of Epidemiology and Infection June and September 2001;16:62-66. 11. Webber LM. Richards P, Grey S. HIV education in South Africa: where are we going? Southern African Journal of HIV Medicine August 2001;5:40-43. 12. Taylor MB, Muller T, Bekker PJ, Webber LM. Steynberg MC, Frost FJ, Grabow WOK. Cryptosporidium antibodies amongst swimmers and canoeists in South Africa. Letter, Water SA Second Half Reviews, 2003. 13. Webber LM. Cotton M, Stevens W. Guidelines: Diagnosis of perinatal HIV infection in South Africa. Southern African Journal of HIV Medicine August 2001;5:21-26. 13 14 Van Wyk S, von Brandis-Martini P, Pretorius HW, Webber LM. Grimbeeck RJ, Mokoape CN, Molopyane SM, Sekgothe MJ, Thantsa OM. HIV prevalence on 200 selected patients at Weskoppies Hospital. Southern African Journal of Epidemiology and Infection 2004;19(2):63-68. 15 Webber LM. The role of HIV oral fluid testing in South Africa. Southern African Journal of HIV Medicine December 2001;6. 16. Webber LM. Post exposure prophylaxis in the occupational health care setting. Southern African Journal of HIV Medicine March 2002:8-9. 17. Van Rooyen, Webber LM. HIV and allergy. Southern African Journal of HIV Medicine December 2001:40-42 18. Webber LM. Therapeutic interventions; the role in the fight against global public health problem of hepatitis B. Southern African Journal of Epidemiology and Infection September supplement 2002(17):31-33. 19. Modi SL, Webber LM. HIV infection in India: following in the footsteps of South Africa? Southern African Journal of HIV Medicine August 2003:46-48. 20 Webber LM, Rautenbach PGD. Exposure to bloodborne pathogens – general precautions. Southern African Journal of HIV Medicine, August 2003:24-28. 21. Modi SL, Webber LM. HIV invasion of China – warning bells for South Africa? Southern African Journal of Epidemiology and Infection 2004; 19(3,4):80-82. 22. Webber L, Heney C. HIV and herpes simplex virus: the grave consequences of co- infection. Health and Hygiene, July 2004;15(7):12-14. 23. Webber L. HIV infection – why is the virus still winning the battle? Health and Hygiene 2004;15(12):5-6. 24. Huyser C, Luskutoff NM, Singh R, Morris L, Webber L. Semen washing of Spiked HIV positive semen samples: a reproductive biologist‟s practical experience. Scientific Letter to South African Journal of Medicine, July 2004;15:17. 25. Webber LM and South African HIV Clinicians Society Expert Committee. Pre-ART Guidelines: amended November 2004. Southern African Journal of HIV Medicine November 2004;17:18-30. 26. Stevens W, Sherman G, Cotton M, Gerntholtz L, Webber L. Revised guidelines for the diagnosis of perinatal HIV-1 infection in South Africa. Southern African Journal of HIV Medicine March 2006:24-28. 27. Modi S, Webber LM. Ritonavir boosting – unravelling the mystery. Southern African Journal of HIV Medicine, September 2006:23-26. 14 28. Webber L. Viruses and cancers: a short discussion on some prognostic determinants. Menopause 2007:10;6-7. 29. Webber L. Young Researcher‟s Guide. From a practising medical doctor to a confident researcher:starting an academic paper.The Specialist Forum 2009;9(3):46-47. (This article received Best Overall Publication – Qualitative Research, runnerup, at the Faculty of Health Sciences, University of Pretoria, 2010) 30. Webber LM. From animals to humans or humans to animals: the emergence of zoonotic viruses. The Specialist Forum 2009;10:11-15. 31. Webber LM. International AIDS Society Conference 2009: translating science into practice. The Specialist Forum 2009;10: 32-36. 32. Webber LM, Human S. Viruses affecting the musculoskeletal system: selected South African arboviral examples. South African Journal of Rheumatology2010;2: 22-29. 33. Webber LM. Guest editorial: why do viruses keep their genome so small. Continuing Medical Education (CME) 2011;29(5):189-190. 34. Bowyer SM, Sim JGM, Webber LM. Current laboratory diagnosis of hepatitis B virus infection, including 8 years of retrospective laboratory data. Continuing Medical Education (CME), 2011;29(5): 210-213. 35. Morris N, du Toit Prinsloo L, Webber L, Saayman G. The prevalence of HIV in Pretoria‟s medico-legal laboratory cases, RSA, in 2009. Occupational Health Southern Africa, 2014;20 (2):6-10. 15 BOOKS, CHAPTERS, PUBLISHED PROCEEDINGS 1. Webber LM. HIV prophylaxis after needlestick injury. MIMS Medical Specialities 1998;3:63. 2. Webber LM. HIV Prophylaxis for occupational related injuries and after sexual assault or rape. In HIV Medicine, lecture notes of the SAMA FPD HIV Medicine Diploma, 2002,South Africa. 3. Webber LM, Botes ME. HIV: diagnosis and treatment. MIMS Medical Specialty Reviews, Update 2003, 2003;342-347. 4. Webber LM. HIV and the management of opportunistic infections. MIMS Medical Specialty Reviews, Update 2003, 2003:349-354. 5. Webber LM. HIV and post exposure prophylaxis. Proceedings of the NOSHCON Health and Safety Congress, 18-23 June 2003, Sun City, South Africa. 6. Loskutoff NM, Huyser C, Singh R, Morfield KA, Walker D, Thornhill AR, Smith M, Morris L, Webber L. A novel and effective procedure for removing HIV-1 RNA from human semen. International Congress Series: special issue. Proceedings of the 18th World Congress on Fertility and Sterility (IFFS 2004). Editors: Daya S, Pierson R and Gunby J. (2004) 7. Webber L. Chapter 16. Post exposure prophylaxis. In HIV/AIDS Clinical Management Programme for the Foundation of Professional Development, Edition 2 January 2004. 8. Petersen A, Webber L. Assistant author of report. Ethical dimensions of HIV/ AIDS. Pugwash meeting no: 310. 3rd Pugwash Workshop on Science, Ethics and Society. Ajaccio, Corsica, France, 29 – 02 October 2005. 9 Webber L. Chapter 16: Post exposure prophylaxis. In HIV/AIDS Management for Professional Nurses for the Foundation for Professional Development, Edition 2, January 2006. (by Sue Roberts and Kathy Dennil). 10. Webber L. HIV in the Workplace. Proceedings; Annual Dentistry Congress, Sun City, 4- 6 August 2007. 11. Webber LM. Hepatitis viruses in South Africa. MIMS Medical Specialities, published March 2007. 12. Brink G, Schoub B, de Frey A, Ross M, Webber L et al. Guidelines for the 16 vaccination of a traveller. Congress Proceedings of the Travel Medicine Society of Southern Africa, 2007. 13. Webber LM. The pathogenesis of HIV-1 infection and disease progression. Chapter Two in the book entitled “HIV/AIDS: a clinical resource for communication, hearing and swallowing disorders, eds De Wet Swanepoel, Brenda Louw, Plural Publishing, San Diego, CA, first edition, 2010. 14. Webber LM. Viral hepatitis. MIMS Medical Specialities, April 2010. 15. Webber LM. Antiretroviral Therapy. MIMS Medical Specialities, April 2010. 16. Webber LM. Editor: the integrated management of TB, HIV and STI in the primary healthcare setting. Edition 2, June 2011, published through the Foundation for Professional Development, Lynnwood Ridge, South Africa. 17 PAPERS, POSTERS, INVITED LECTURES AND PLENARY PRESENTED AT SCIENTIFIC AND MEDICAL MEETINGS SESSIONS 1. Webber LM. Els S, Taylor MB, Grabow WOK. Hepatitis C virus serotyping: assessment of a commercial enzyme immunoassay. Poster presentation. BUSHPATH „96, 36th Annual Congress of the Federation of South African Societies of Pathology, 29 June - 3 July 1996: Karos Kruger Lodge, Mpumalanga, South Africa 2. Webber LM. Grabow WOK, Favorov MO. Assessment of techniques for the detection of hepatitis E virus antibodies. Oral paper. 23 rd Faculty Day, Faculty of Medicine, University of Pretoria, 27 - 28 August 1996, Pretoria 3. Webber LM. Grabow WOK. Occupational exposure of health-care workers and students to HIV and HBV. Poster presentation. 24th, Faculty Day, Faculty of Medicine, University of Pretoria, 26 - 27 August 1997, Pretoria 4. Ionescu GO, Kirsten M, Webber LM. Dinkel JE, Banieghbal B, Fonesca J. Implications of HIV positive status in paediatric surgery: a preliminary study. Oral presentation. Paediatric Surgical Conference, 20 - 24 February 1998, Cape Town 5. Webber LM. du Plessis R, Scholtz L, Nel E, Saayman G. Bloodborne viral pathogens and autopsies: is there cause for concern. Oral presentation. FUTUREPATH „98, 38th annual congress of the Federations of South African Societies of Pathology, University of Pretoria, 28 June - 1 July 1998, Pretoria 6. Clay CG, Vivier C, Erasmus D, Webber LM. Taylor MB. The value of enteroviral RT-PCR in the diagnosis of acute viral central nervious system. Oral presentation. FUTUREPATH „98 - 38th annual congress of the Federations of the South African Societies of Pathology, University of Pretoria, 28 June - 01 July 1998, Pretoria 7. Webber LM. Swanevelder C, Grabow W, Fourie B. Detection of HIV antibodies in serum, plasma and saliva using test-strips: a pilot study. Oral presentation. FUTUREPATH „98 8. Botha ME, Webber LM. GrabowW. A rubella outbreak amongst medical and dental students at the University of Pretoria. Oral presentation. FUTUREPATH „98 9. Webber LM. Retief J, Vivier C, Davel G, Grabow W. Acute hepatitis E: a case study. Oral presentation. FUTUREPATH „98 10. Webber LM. du Plessis R, Saayman G. Seroprevalence of bloodborne viruses in forensic autopsies. Oral presentation. Virology Congress of Southern Africa, UCT Waterfront Campus, 28 - 30 October 1998, Cape Town 11. Webber LM. du Plessis R, Els S, Saayman G. Bloodborne viral pathogens and autopsies: is there cause for concern? Oral presentation. 25th Faculty Day, Faculty of Medicine, University of Pretoria, 25 - 26 August 1998, Pretoria 12. Webber LM. Swanevelder C, Grabow W, Fourie B. 18 Rapid testing for HIV antibodies: a pilot study. Poster presentation. Virology Congress of Southern Africa, UCT Waterfront Campus, 28 - 30 October 1998, Cape Town 13. Grabow W, Vivier JC, Clay CG, Webber LM. Detection of hepatitis E in serum and stool specimens of South African patients. Oral presentation. Virology Congress of Southern Africa, UCT Waterfront Campus, 28 - 30 October 1999, Cape Town 14. Webber LM. du Plessis R, Saayman G. Bloodborne viruses in forensic medicine in South Africa. Poster presentation and oral presentation. XIth International Congress of Virology, 9 - 13 August 1999, Sydney 15. Webber LM. Needlestick injuries. Oral presentation. International Association for Dental Research, 27 August 1999, Krugersdorp 16. Webber LM. Bloodborne viruses and needlestick injuries. The South African Society of Occupational Medicine Congress, CSIR, 30 July 1999, Pretoria 17. Moloto MJ, Burnett R, Webber LM, Mogotlane SM, Aspinall S and Mphahlele MJ. Investigation of hepatitis B virus surface gene variants in South Africa. MEDUNSA Academic Day, July 1999, Pretoria 18. Mphahlele MJ, Jensch S, Clay CG, Moloto MJ, Smit EJ, van der Merwe CF, Webber LM. HBV viral load testing: clinical significance and choice of the assay. MEDUNSA Academic Day, July 1999, Pretoria 19. Molefe A, Clay C, Webber LM. HIV diagnostic dilemmas: survey from a virology laboratory. Poster presentation. Lesedi Afrika „99, IUSTI/STD/HIV 6th World Congress and 38th IUSTI General Assembly, Sun City, 21 - 24 November 1999 20. Moloto MJ, Burnett RJ, Webber LM. Mogotlane SM, Aspinall S, Mphahlele MJ. Investigation of hepatitis B virus surface gene variants in South Africa. Poster presentation. Lesedi Afrika „99, IUSTI/STD/HIV 6th World Congress and 38th IUSTI General Assembly, Sun City, 21 - 24 November 1999 21. Mphahlele MJ, Jensch S, Clay CG, Moloto MJ, Smit EJ, van der Merwe CF, Webber LM. Clinical significance of HBV viral load testing in South Africa. Poster presentation. Lesedi Afrika „99, IUSTI/STD/HIV 6th World Congress and 38th IUSTI General Assembly, Sun City, 21 - 24 November 1999 22. Botha ME, Vivier JC, Webber LM. Grabow WOK, Clay CG. Enteroviral infections: how many cases are we missing? Poster presentation. Lesedi Afrika „99, IUSTI/STD/HIV 6th World Congress and 38th IUSTI General Assembly, Sun City, 21 - 24 November 1999 23. Webber LM. Richards PDG, Grabow WOK, Taylor MB. Basic medical virology practical sessions: does the student really benefit? Poster presentation. IX International Ottawa Congress on Medical Education, Cape Town, 28 February - 01 March 2000 19 24. Webber LM. Broodryk F, Richards PA. The implications of HIV prophylaxis for health care students. Oral presentation. IX International Ottawa Congress on Medical Education, Cape Town, 28 February - 01 March 2000 25. Webber LM. HIV: new concepts. Oral presentation. Dermatology Congress 2000, Sun City, 30 March - 2 April 2000 26. Webber LM. HIV: new developments and current concepts. Oral presentation. Maxillo-Facial and Oral Surgeons Congress 2000, Valley Lodge, Magaliesberg, 1-3 June 2000 27. Jeffery BS, Webber LM, Mohondo R. Pretoria pasteurisation study. presentation. XIII International AIDS Conference, Durban 9-14 July 2000 28. Jeffery BS, Webber LM. Mokhondo R. Determination of the effectiveness of Pretoria Pasteurisation to inactivate HIV in human milk. Poster presentation. XIII International AIDS Congress, Durban, 9-14 July 2000 29. Webber LM. du Plessis R. Bloodborne viruses in forensic medical practice: a sherp rise in HIV seroprevalence. Oral presentation. Path 2000 Congress, Warmbaths, 2-5 July 2000 30. Botha ME, Viviers C, Webber LM. Grabow WOK. Enteroviral infections: how many cases are we missing? Oral presentation. Path 2000 Congress, Warmbaths, 2-5 July 2000 31. Moloto MJ, Burnett RJ, Webber LM. Mphahlele MJ, Naturally occurring HBV surface gene variants from serologically negative HBV infections and HBsAg carriers. Oral presentation. Path 2000 Congress, Warmbaths, 2-5 July 2000 32. Webber LM. Bloodborne viruses and the funeral industry in South Africa. Oral presentation. Path 2000 Congress, Warmbaths, 2-5 July 2000 33. Webber LM. Therapeutic interventions in the fight against the global public health problem of hepatitis B. Oral presentation. VLR Network Hepatitis B International Meeting, Johannesburg, 15-16 May 2001 34. Webber LM. Future directions for the control and management of hepatitis B in Sub Saharan Africa. Oral presentation. VLR Network Hepatitis B International Meeting, Johannesburg, 15-16 May 2001 35. Webber LM. Guide 15189 for the accreditation of medical laboratories. Oral presentation. International Meeting on the Accreditation of Medical Laboratories, 08 June 2001, Cape Town 36. Pretorius HW, van Wyk S, von Brandis-Martini P, Webber LM. Grimbeeck RJ, Mokoape CN, Molopyane SM, Sekgothe MJ, Thantsa OM. The prevalence of HIV infection in two hundred successive admissions to a psychiatric hospital in Gauteng a pilot study. Poster presentation. South African Biological Psychiatry Congress, 20 Oral Pretoria, October 2001 37. Webber LM. Measurement uncertainty in HIV testing repeatedly revisited. Oral presentation. NLA Test and Measurement Congress, Pretoria, 10 - 12 September 2001 38. Webber LM. HIV prevention of mother/child transmission and perinatal treatment. Medicine Update Congress for the General Practitioner. 15 -16 September 2001 39. Webber LM. HIV epidemiology. The South African Head and Neck Oncology Society Congress, Pretoria, 5 - 6 October 2001 40. Webber LM. Erasmus D, Mhkondo R, Jeffery B. Measurement and propagation of HIV-1 in breast milk from selected patients in South Africa. Oral presentation. Infectious Diseases and STD Congress, 2 - 6 December 2001, Cape Town 41. Webber LM. Post exposure prophylaxis in the occupational setting. Oral presentation. Infectious Diseases and STD Congress, 2 - 6 December 2001, Cape Town 42. Van Rooyen C, Webber LM. Evaluation of the laboratory diagnosis of respiratory syncytial virus (RSV) infection. Poster presentation. Infectious Diseases and STD Congress, 2 - 6 December 2001, Cape Town 43. Webber LM. Hepatitis C virus: a true mistress of deception. Oral presentation. Test and Measurement Congress, 16 August 2002, Roodevallei Lodge, Pretoria 44. Loskutoff NM, Huyser C, Webber L, Morgan C, Snyckers D. Determining the efficacy of the Novel Semen Disinfection procedure for eliminating HIV and hepatitis B and C viruses from the semen of infected humans. Oral presentation. 3rd Annual Embryology Summit Conference, Mayo Clinic, Rochester, Minnesota, USA – 21 September 2002. 45. Zingela Z, Esterhuizen F, Kruger C, Webber LM. Prevalence of HIV infection in a group of adult psychiatric in-patients from two wards ant the Weskoppies Hospital. Poster presentation. National psychiatry Conference, Cape Town, 23-28 September 2002 46. Koorts P, Webber LM. Kruger M. HIV oral fluid testing in paediatric populations. Poster presentation. In preparation for national paediatric society annual congress. October 2002. 47. Webber LM The changing face of medicine in emerging and re-emerging diseases. Symposium: the threat of emerging and re-emerging diseases to global health security. Oral presentation. Pretoria Technikon, Pretoria, 4 - 5 September 2002 48. Webber LM, Jentsch U, Mokgatle Z. Compensation on occupationally acquired HIV/AIDS; technical issues related to South Africa. Oral Presentation. Medical Virology Congress of South Africa, 18-21 May 2003, Kruger National Park, South 21 Africa. 49. Gove E, Webber LM. Rapid assays to distinguish between viral and inhalation anthrax associated influenza-like illness (ILI). Oral presentation. Medical Virology Congress of South Africa, 18-21 May 2003, Kruger National Park, South Africa. 50. Webber LM. Vaccines: exciting discoveries. Guest Speaker and Oral presentation. Medical Virology Congress of South Africa, 18-21 May 2003, Kruger National Park, South Africa. 51. Webber LM, Botes ME, Hills J, Botma K. Oral fluid testing for HIV antibodies for South African conditions. Poster presentation. Medical Virology Congress of South Africa, 18-21 May 2003, Kruger National Park, South Africa. 52. Modi SL, Webber LM. HIV epidemic: can India learn from South Africa? Poster. Medical Virology Congress of South Africa, 18-21 May 2003, Kruger National Park, South Africa. 53. Webber LM. Jeffery B, Tlale EM, Mokhondo R. HIV RNA measurement in human breast milk: a comparative evaluation of two methods. Poster. Medical Virology Congress of South Africa, 18-21 May 2003, Kruger National Park, South Africa. 54. Nieman HLJ, Webber LM, Botes ME. Occult hepatitis B infection in HIV-infected individuals: reason for concern? Poster. Medical Virology Congress of South Africa, 18-21 May 2003, Kruger National Park, South Africa. 55. Seautlweng R, Webber LM, Madumo JS. Occupational HIV exposure events; can trends identified assist in prevention? Poster. Medical Virology Congress of South Africa, 18-21 May 2003, Kruger National Park, South Africa. 56. Webber LM. HIV and occupational exposure risks. Oral presentation. NOSHCON Health and Safety Congress, 18-23 June 2003, Sun City, South Africa. 57. Webber LM, Taylor MB. HIV and groundwater: a grave concern for South Africa? Poster. International Water Conference, 18-23 September 2003, Cape Town, South Africa. 58. Webber LM. HIV and post exposure prophylaxis. SA Blood Transfusion Services Academic Workshop, 14 August 2003, Alpha Training Centre, Broederstroom, Pretoria, South Africa. 59. Webber LM. Vaccine resistance. Oral presentation. Travel Medicine and Parasitology Congress, 07 October 2003, Farm Inn, Pretoria, South Africa. 60. Webber LM. Viral technology. Plenary Speaker. Emerging Infectious Diseases International Conference, 05 May 2004, CSIR, Pretoria, South Africa. 61. Loskutoff NM, Singh R, Huyser C, Morfield KA, Walker D, Thornhill AR, Smith M, Morris L, Webber L. . A novel and effective procedure for removing HIV from 22 human semen. Oral presentation. IFFS 18th World Congress on Fertility and Sterility, May 23-28, 2004, Montreal, Canada. 62. Skosana JS, Ahmed K, Webber L. Evaluation of HIV rapid test against HIV-RNA PCR. Oral presentation, Medunsa Academic Day 2004, 13 June 2004, Medunsa Faculty, Pretoria, South Africa. 63. Webber LM. New developments in HIV Medicine. Nosa Training and Consulting Services HIV/AIDS seminar, invited speaker, 25 August 2004, Holiday Inn, Pretoria, South Africa. 64. Webber LM. HIV and new developments – part 1. Invited speaker. Oral Health Care Congress, 16 July 2004, Merryll Lynch Board Room, Johannesburg, South Africa. 65. Webber LM. HIV and new developments – part 2. Invited speaker. Oral Health Care Congress, 16 July 2004, Merryll Lynch Board Room, Johannesburg, South Africa. 66. Webber LM. HIV and ethics. South African Society of Orthodontics Academia Day 2004, invited speaker, 10 September 2004, Sandton Convention Centre, Johannesburg, South Africa. 67. Webber LM. HIV 2004 – a grave concern for Southern Africa. Nambian Denta Association Health Care Congress, invited speaker, 30 September 2004, Midgard Lodge, Windhoek, Nambia.. 68. Webber LM. Opportunistic infections. Nambian Dental Association Health Care Congress, invited speaker, 01 October 2004, Midgard Lodge, Windhoek, Nambia. 69. Webber LM. Antiretroviral therapy. Nambian Dental Association Health Care Congress, invited speaker, 02 October 2004, Midgard Lodge, Windhoek, Nambia. 70. Webber LM. HIV: disease profile and policies for the workplace. Club Xchange Annual Meeting, South African Finance Houses, invited speaker, 04 October 2004, Nedbank Mangement Centre, Muldersdrift, South Africa. 71. Webber LM. HIV: new developments and concerns for Southern Africa. South African Dental Associaton, Limpopo Province Branch, Annual Dental Course, invited speaker, 09 October 2004, Polokwane Country Club, Polokwane, South Africa. 72. Webber LM. HIV in the workplace. Guest speaker. Oral Health Promotion and Information Care Congress, 19 November 2004, Gallagher Estate, Midrand, South Africa. 73. Webber LM. HIV – a grave concern for South Africa. HIV/AIDS Integration Conference, Invited Speaker, Sammy Marks Building, Pretoria, 19 November 2004. 74. Webber LM. New developments in HIV medicine and preventative aspects. Mines and Hospital Associations. Oral presentation, Rustenburg Golf Club, Rustenburg, 17 March 2005. 23 75. Webber LM. HIV and Immunology. Continuous Medical Education Seminar, Northern Branch, Venda Sun, Thohoyandou, 02 April 2005. Oral presentation. 76. Webber LM. Antiretroviral adverse effects and management. Continuous Medical Education Seminar, Northern Branch, Venda Sum, Thohoyandou, 02 April 2005. Oral presentations. 77. Webber LM. HIV preventative strategies. Invited Speaker. International Pugwash Scientific Meeting, Gordons Bay, Cape Town 29 April – 2 May 2005. 78. Webber LM. Invited Guest Speaker. Rubella and other viral diagnostic techniques. Scientific meeting, Roche Headquarters, Munich, Germany, 12 May 2005. 79. Webber LM. National AIDS Conference. Roche Satellite Symposium. New developments – HIV testing continues to expand. Oral presentation and invited speaker. Hilton Hotel, Durban, 08 June 2005. 80. Huyser C, Loskutoff NM, Singh R, Webber L. Quantification of HIV-1 RNA in washed sperm samples. Oral presentation 21st Annual Meeting of the European Society of Human Reproduction and embryology, Copenhagen, Denmark, 19-22 June 2005. 81. Webber LM. Infection Control in Virology – what the textbooks do not teach us? The 2nd Hospital Acquired Infections Africa 2005 Conference and Workshop. Oral presentation Hilton Hotel, Sandton, Johannesburg, South Africa, 4-6 July 2005. 82. Webber LM. Plenary speaker. The importance of measurement. National Laboratory Association: Test and Measurement Conference 2005, Emporer‟s palace, Gauteng, 57 September 2005. 83. Webber LM. Invited speaker and chairperson. HIV preventative strategies – ethical dimensions? 3RD International Pugwash workshop on Science, Ethics and Society: Ethical HIV/AIDS dimensions of HIV/AIDS in developing countries, Ajaccio, Corsica, France, 29 September – 02 October 2005. 84. Webber LM. Invited speaker. HIV and Southern Africa. Southern Branch of the Medical Technology Society Conference. Mine Hospital, Orkney, Gauteng, 08 October 2005. 85. Webber LM. Guest speaker. Viruses, including HIV. Branch of the South African Dental Society Annual Meeting, Klerksdorp, Gauteng, 08 October 2005. 86. Webber LM. Preventative strategies for HIV in Southern Africa. Guest speaker. Out of Africa Medical Conference, Swakopmund Casino and Hotel, Swakopmund, Namibia, 19-23 October 2005. 87. Webber LM, Ebraheim O. HIV – positive: but where is the virus? Oral presentation. Virology Africa 2005 Conference, UCT Graduate School of Business 24 and Breakwater Lodge, Cape Town, 8-11 November 2005. 88. Tsilimigras C, Webber L. Detection of human papillomavirus genotypes in clinical specimens. Oral presentation. Virology Africa Conference, UCT Graduate School of Business and Breakwater Lodge, Cape Town, 8-11 November 2005. 89. Webber L. The impact of avian influenza. Oral presentation. Faculty of Medicine Infectious Diseases Forum, Medical Campus, University of Pretoria, 27 March 2006. 90. Webber L. Avian influenza in South African Oral presentation. The Society of Sciences and Associated Sciences in South Africa (S2A3), University of Pretoria Main Campus, 05 April 2006. 91. Webber L. HIV in the Workplace: Management and Awareness. Oral presentation. Strategic Management of HIV in the Workplace Workshop, Gold Reef City, Crown Reef Conference Centre, Johannesburg, 24-26 April 2006. 92. Webber L. Introduction to Infection Control Practices. Guest speaker. Acquired Hospital Infections and Good House Keeping Practices: international best practices in combating nosocomial infections Conference, Karos Indaba Hotel, Fourways, Johannesburg, 05 – 07 June 2006. 93. Webber L. Immunology in Travel Medicine. Invited Speaker. Society of Travel Medicine Gauteng Meeting, Rosebank Hotel, Johannesburg, 20 May 2006. 94. Webber L. Avian influenza: Time flies…? Plenary Speaker. The Centre for International Political Studies at the University of Pretoria and the South African National Pugwash Group Seminar, Main Campus, University of Pretoria, 30 May 2006. 95. Webber L. Treatment and care of diseases relevant to our time and country: HIV/AIDS. Guest Speaker. Third Annual Symposium on Diseases Relevant to South Africa. The School of Pharmacy, Faculty of Health Sciences of the North-West University and the North West Branch of the Pharmaceutical Society of South Africa. Potchefstroom Campus, South Africa, 14-15 July 2006. 96. Webber L. Strategic use of antivirals for pandemic and seasonal influenza. Guest Speaker. Training and Sponsored Meeting for Professional Education Network and Life Flora Clinic, Flora Clinic Training Room, Johannesburg, 25 July 2006. 97. Webber L. New developments in virology. Invited speaker. South African Society of Optometry Annual Congress, Gallagher Estate, Midrand, 17 September 2006. 98. Webber L. Viruses and Cancer. Plenary Speaker. Multi-Disciplinary Approach to Gynaecological Cancers Annual Meeting, Sandton Convention Centre, 17 November 2006. 99. Ebraheim O, Webber L, Tsilimigras C. CMV infection in an immuno-competent HIV-infected patient: Are we missing cases? In submission to the 3rd South African 25 AIDS Conference: 2007, Durban, as a poster presentation. 100. Pool N, Trusler J, Webber L, Tsilimigras C. Lower analytical range sensitivity comparison between the Roche Cobas Amplicor assay and the Roche Cobas Taqman assay for HIV-1 RNA viral load testing. In submission to the 3rd South African AIDS Conference, 2007, Durban, as a poster presentation. 101. Webber L. HIV in the workplace. Invited speaker, South African Society for Occupational Medicine (SASOM) Congress, 08 March 2007, Cape Town. 102. Webber L. HIV in the workplace. Plenary speaker. Annual Dentistry Congress, 4-6 August 2007, Sun City. 103. Webber L. HIV in the workplace. Invited speaker. SASOM Congress, CSIR Conference Centre, August 2007. 104. Webber L. Human papillomavirus and cervical cancer. Plenary speaker. Roche Diagnostics Forum, 10 September, Johannesburg 2007. 105. Webber L. Respiratory viruses and avian influenza/pandemic. Invited speaker. Travel Medicine Congress, 27 September 2007, Kopanong Hotel, Benoni, Johannesburg. 106. Webber LM. Virology Updates. Invited speaker, Women in Dentistry Workshop, Caesar‟s Palace, Johannesburg, 21 September 2008. 107. Webber LM. New developments in virology for technologists. Guest speaker. Southern Branch of Medical Technologists Congress, AngloGold Ashanti and West Vaal Hospital, North West Province, 11 October 2008. 108. Webber LM. Respiratory aspects of virology. Guest speaker. Continuing Medical Training Workshop, Garden Court Hotel, Cape Town, 24 October 2008. 109. Webber LM. HIV resistance testing. Invited speaker. Pretoria HIV Resistance Group, Brooklyn, Pretoria, 26 November 2008. 110. Webber LM, Sifris D, Myhre J, Ward S. Prevalence of anti-R7V antibodies in a cohort of HIV-infected South African patients on HAART. Oral presentation. HIV and AIDS Research Indaba, University of Pretoria, 26-27 February 2009. 111. Webber L. Cytomegalovirus infection in an immunocompetent HIV-infected patient: are we underestimating its presence? Oral presentation. HIV and AIDS Research Indaba, University of Pretoria, 26-27 February 2009. 112. Webber L. HIV in the workplace. Invited speaker. International Congress of Occupational Health, Cape Town, 23-27 March 2009. 113. Webber L. HIV updates 2009. Invited lecturer. Pretoria Doctors Academic Group, Garden Court Holiday Inn, Pretoria, 15 May 2009. 26 114. Webber L. Invited speaker. New aspects in virology. Johannesburg Doctors Group, Protea Hotel, Midrand, 12 May 2009. 115. Webber LM. Plenary speaker.Viruses emerging in the dentitstry disciplines. NorthWest Dental Conference, 06 June 2009, Holiday Inn, Potchefstroom. 116. Webber LM. Invited lecturer. CMT Conference for Dentists, Kopanong Hotel, Gauteng, 05 June 2009. 117. Webber LM. Invited speaker. New updates on viral post exposure prophylaxis. South African HIV Clinicians Society, Muelmed Hospital board room, Pretoria, 02 July 2009. 118 Webber LM. Diagnostic developments in HIV testing and monitoring with a Swine „flu update. Gauteng Northern Branch, South African Medical Association, 20 August 2009, CSIR Conference Centre, Invited speaker. 119 Webber LM. Invited speaker. Ethics in infectious diseases, Congress For Continuing Medical Training, Kopanong Hotel, 05 September 2009 Benoni, Gauteng 120 Webber LM. Invited speaker. New developments in virology. Afrikaners Dokters Vereenigning Congress, ALV Building, 11 September 2009, Pretoria. 121 Webber LM. Post-exposure prophylaxis. Midrand Conference Centre, 16 October 2009, Gauteng Province 122 Webber LM. How should the approach to teaching medicine change? Oral presentation. University of Pretoria HIV and AIDS Research Indaba, 27 February 2010, SRC Chambers, University of Pretoria 123 Webber LM. HIV drug resistance testing: a case study from Kenya, University of Pretoria HIV and AIDS Research Indaba, 28 February 2010, SRC Chambers, University of Pretoria Webber LM. Virus ontwikkelinge. Invited speaker, Afrikaners Dokters Vereniging Congress, Pretoria, 12 March 2010. 124 125 Webber LM. Virology Updates. Invited speaker, Smile for Joy Congress, Oral Hygiene for HIV Orphans, Bronkhorstspruit, 01 May 2010. 126 Webber LM. Plenary speaker. Developments in AIDS management, North-West Dental Conference, Potchefstroom University, 06 June 2010. 127 Webber JM. Comprehensive HIV and AIDS Care, Management and Treatment for South Africa, 16-20 August 2010, Department of Defence, Thaba Tshwane, SANDF Training Centre, Pretoria 27 128 Webber LM. Invited speaker. Infectious Diseases for the Sports-person, MSc Sports Medicine Course, 19 August 2010, Department of Orthopaedics, Sports Centre, University of Pretoria. 129 Webber LM. Invited Speaker. HIV Resistance; Clinical Relevance. HIV-1 Resistance Interest Group, 01 September 2010, Die Werf Conference Centre, Pretoria. 130 Webber LM. Plenary Speaker. HIV Updates, HIV Seminar, South African Medical Association Congress, CSIR, Pretoria, 15 September 2010. 131 Webber LM. Die Soonose – gevaar vir die mens”, Afrikaanse Doketrs Verening, Transvaal Landbou Unie, 15 September 2010, Pretoria. 132 Webber LM. Guest Speaker, “Does leprosy deserve attention and is there a right to die?” WHO World Leprosy Day, Adrianus Pijper Lecture Room, Institute of Pathology, 31 January 2011, Pretoria. 133 Webber LM. Invited Speaker. Management and Prevention of Viral Infections, CMT Dental Conference, 5-7 May 2011, Kopanong Conference Centre, Benoni, South Africa. 134 Webber LM. Invited Speaker. Latest Developments in HIV Diagnosis and Prevention. 14th Annual Conference of the Medical Mineworkers Professional Association, Sparkling Waters Conference Centre, Rustenburg, South Africa, November 2011. 135 Webber LM. Ticks, fleas, mosquitoes, flies and viruses. Guest presenter. Medical ethics, legislation and bundu bashing Congress. South African Society of Occupational Medicine, Bundu Lodge, White River, South Africa, 24 November 2012. 136 Webber LM. Plenary speaker. Viruses in dentistry. South African Dental Association (SADA), North West Branch, Garden Court hotel, Potchefstroom, 31 August 2013. 137 Webber LM. Guest speaker. Hepatitis A and B. Hepatitis Meeting. Aspen-pharma, Emperor‟s Palace, South Africa, 09 January 2014. 138 Webber LM. Invited lecturer. Viral hepatitis. Aspen National Sales Congress. Emperor‟s Palace, 11 January 2014. 139 Webber LM. Key note speaker. Updates on HIV. ARAOH/SASOM Congress. Emperor‟s Palace, South Africa, 1-3 August 2014 140 Webber LM. Invited speaker. Ebola and viral hepatitis. Illovo Hotel, Johannesburg, South Africa, 13 August 2014, Aspen Open Day and National Sales Conference. 28 141 Webber LM. Invited speaker. Challenges of healthcare worker exposures. BD Safety Summit, Radisson Blu Gautrain Hotel, 20 August 2014. 142 Webber LM. Guest speaker. Managing the risk of travel in the mining industry: an update on Ebola, meningococcal meningitis and other infections. Mine Medical Professionals Association 17th Annual Congress, Kloofzicht Lodge, Muldersdrift, South Africa, 05-06 September 2014. 29
© Copyright 2024 Paperzz